» Articles » PMID: 29892290

Exposure of Human CD8 T Cells to Type-2 Cytokines Impairs Division and Differentiation and Induces Limited Polarization

Overview
Journal Front Immunol
Date 2018 Jun 13
PMID 29892290
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Effector CD8 T cells generally produce type-1 cytokines and mediators of the perforin/granzyme cytolytic pathway, yet type-2-polarized CD8 cells (Tc2) are detected in type-2 (T2) cytokine-driven diseases such as asthma. It is unclear whether T2 cytokine exposure during activation is sufficient to polarize human CD8 T cells. To address this question, a protocol was developed for high-efficiency activation of human CD8 T cells in which purified single cells or populations were stimulated with plate-bound anti-CD3 and anti-CD11a mAb for up to 8 days in T2 polarizing or neutral conditions, before functional analysis. Activation of CD8 naïve T cells (T) in T2 compared with neutral conditions decreased the size of single-cell clones, although early division kinetics were equivalent, indicating an effect on overall division number. Activation of T in T2 conditions followed by brief anti-CD3 mAb restimulation favored expression of T2 cytokines, GATA3 and , and lowered expression of type-1 cytokines, , Gzmb, T-BET, and . However, IL-4 was only weakly expressed, and PMA and ionomycin restimulation favored IFN-γ over IL-4 expression. Activation of T in T2 compared with neutral conditions prevented downregulation of costimulatory (CD27, CD28) and lymph-node homing receptors (CCR7) and CD95 acquisition, which typically occur during differentiation into effector phenotypes. CD3 was rapidly and substantially induced after activation in neutral, but not T2 conditions, potentially contributing to greater division and differentiation in neutral conditions. CD8 central memory T cells (T) were less able to enter division upon reactivation in T2 compared with neutral conditions, and were more refractory to modulating IFN-γ and IL-4 production than CD8 T In summary, while activation of T in T2 conditions can generate T2 cytokine-biased cells, IL-4 expression is weak, T2 bias is lost upon strong restimulation, differentiation, and division are arrested, and reactivation of T is reduced in T2 conditions. Taken together, this suggests that exposure to T2 cytokines during activation may not be sufficient to generate and retain human Tc2 cells.

Citing Articles

Type-2 CD8 T-cell formation relies on interleukin-33 and is linked to asthma exacerbations.

van der Ploeg E, Krabbendam L, Vroman H, van Nimwegen M, de Bruijn M, de Boer G Nat Commun. 2023; 14(1):5137.

PMID: 37612281 PMC: 10447424. DOI: 10.1038/s41467-023-40820-x.


Gene-Smoking Interaction Analysis for the Identification of Novel Asthma-Associated Genetic Factors.

Cha J, Choi S Int J Mol Sci. 2023; 24(15).

PMID: 37569643 PMC: 10419280. DOI: 10.3390/ijms241512266.


Development of Adaptive Immunity and Its Role in Lung Remodeling.

Esnault S, Jarjour N Adv Exp Med Biol. 2023; 1426:287-351.

PMID: 37464127 DOI: 10.1007/978-3-031-32259-4_14.


CD8-positive indolent T-Cell lymphoproliferative disorder of the gastrointestinal tract: A case report and review of literature.

Weng C, Ye C, Fan Y, Lv B, Zhang C, Li M World J Clin Cases. 2022; 10(15):4971-4984.

PMID: 35801019 PMC: 9198890. DOI: 10.12998/wjcc.v10.i15.4971.


Transcriptomic analysis reveals optimal cytokine combinations for SARS-CoV-2-specific T cell therapy products.

Durkee-Shock J, Lazarski C, Jensen-Wachspress M, Zhang A, Son A, Kankate V Mol Ther Methods Clin Dev. 2022; 25:439-447.

PMID: 35506060 PMC: 9050197. DOI: 10.1016/j.omtm.2022.04.013.


References
1.
Harland K, Day E, Apte S, Russ B, Doherty P, Turner S . Epigenetic plasticity of Cd8a locus during CD8(+) T-cell development and effector differentiation and reprogramming. Nat Commun. 2014; 5:3547. PMC: 3974221. DOI: 10.1038/ncomms4547. View

2.
Seneviratne S, Black A, Jones L, di Gleria K, Bailey A, Ogg G . Interleukin-4 promotes human CD8 T cell expression of CCR7. Immunology. 2006; 120(1):66-72. PMC: 2265870. DOI: 10.1111/j.1365-2567.2006.02478.x. View

3.
Zediak V, Johnnidis J, Wherry E, Berger S . Cutting edge: persistently open chromatin at effector gene loci in resting memory CD8+ T cells independent of transcriptional status. J Immunol. 2011; 186(5):2705-9. PMC: 3474546. DOI: 10.4049/jimmunol.1003741. View

4.
Rao R, Li Q, Odunsi K, Shrikant P . The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin. Immunity. 2010; 32(1):67-78. PMC: 5836496. DOI: 10.1016/j.immuni.2009.10.010. View

5.
Wei G, Abraham B, Yagi R, Jothi R, Cui K, Sharma S . Genome-wide analyses of transcription factor GATA3-mediated gene regulation in distinct T cell types. Immunity. 2011; 35(2):299-311. PMC: 3169184. DOI: 10.1016/j.immuni.2011.08.007. View